Biopolym. Cell. 1993; 9(6):21-30.
Огляди
Своєрідність біологічних ефектів основних метаболітів вітаміну D3
- Інститут біоорганічної хімії та нафтохімії НАН України
вул. Мурманська, 1, Київ, Україна, 02094
Abstract
В огляді узагальнено експериментальні результати вивчення своєрідності біологічних ефектів основних метаболітів вітаміну D3–1,25-діоксивітаміну D3 і
24,25-діоксивітаміну D3. Розглянуто питання синергізму та антагонізму їх дії в організмі і в окремих клітинах. Проаналізовано дані про залежність характеру біологічного
ефекту кожного з похідних від його дози і фізіологічного стану клітини.
Повний текст: (PDF, російською)
References
[1]
Bauman VK. Biochemistry and physiology of vitamin D. Zinatne, Riga, 1989. 480 p.
[2]
Brommage R, DeLuca HF. Evidence that 1,25-dihydroxyvitamin D3 is the physiologically active metabolite of vitamin D3. Endocr Rev. 1985 Fall;6(4):491-511.
[4]
Yamada S, Ino E, Takayama H, Suda T. Metabolism of 24R,25-dihydroxyvitamin D3: an approach from synthetic study. Vitamin D: cheml, biochem. and clin. update. Eds. A. W. Norman et al. Berlin : New York : W. de Gruyter, 1985: 13-22.
[5]
Spirichev V. B., Kon' I. YA. Biological role of fat-soluble vitamins. Itogi nauki i tekhniki. 1989. 3777-159.
[6]
Somjen D, Weisman Y, Berger E. el al. A comparison of the responses to 24R. 25 (OH)2D3 and 1,25 (OH)2D3 by developing skeletal tissue. Vitamin D. Chem., biochem. and clin. update. Ed. W. de Gruyter. Berlin ; New York, 1985: 284-93.
[7]
Sergeev IN, Pletsityĭ KD, Rusnak FI, Spirichev VB. The effect of 24,25-dihydroxyvitamin D3 (dioxyvit) on Ca metabolism and immune status during chronic kidney failure. Vopr Med Khim. 1990;36(4):17-20.
[8]
Alekseeva IA, Spiricheva VB, Blazhevich NV, Sokolova SV, Pereverzeva OG. Comparative evaluation of biological activity of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol in rats. Vopr Med Khim. 1982;28(5):71-8.
[9]
Suda T, Takahashi N, Abe E. Role of vitamin D in bone resorption. J Cell Biochem. 1992;49(1):53-8.
[10]
Rubinder D, Cojocarn T, Popovtzer MM. 24,25-(OH)2D3 attenuates the calcemic effect of l,25(OH)2D3 in rats with reduced renal mass. Vitamin D : Chem Biochem Clin Update. Eds. A. W. Norman et al. Berlin; New York : W. de Gruyter, 1989: 282-3.
[11]
Rambeck WA, Zucker H. Synergistic effects of 1,25(OH)2D3 and 24,25(OH)2D3 on duodenal CaBP in rachitic chicks and on eggshell weight in Japanese quails. Biochem Biophys Res Commun. 1985;126(2):799-804.
[12]
Caffrey JM, Farach-Carson MC. Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J Biol Chem. 1989;264(34):20265-74.
[13]
Wilhelm F, Ross FP, Norman AW. 24R,25(OH)2D3: An allosteric effector of 1,25 (OH)2D3 binding to its chick intestinal receptor. Vitamin D: Chem Biochem Clin Update. Eds A. W. Norman et al. Berlin; New York : W. de Gruyter, 1989: 129-130.
[14]
Costa EM, Hirst MA, Feldman D. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinology. 1985;117(5):2203-10.
[15]
Ornoy A, Lidor C, Atkin I, Edelstein S. Effect of intraepiphysal injection of vitamin D metabolite on healing of rickets in chicks. In: Vitamin D: A chemical, biochemical and clinical update. Ed. W de Gruyter. Berlin; New York, 1985: 314-15.
[16]
Sömjen D, Sömjen GJ, Harell A, Mechanic GL, Binderman I. Partial characterization of a specific high affinity binding macromolecule for 24R,25 dihydroxyvitamin D3 in differentiating skeletal mesenchyme. Biochem Biophys Res Commun. 1982;106(2):644-51.
[17]
Schwartz Z, Swain LD, Ramirez V, Boyan BD. Regulation of arachidonic acid turnover by 1,25-(OH)2D3 and 24,25-(OH)2D3 in growth zone and resting zone chondrocyte cultures. Biochim Biophys Acta. 1990;1027(3):278-86.
[18]
Boyan BD, Schwartz Z, Carnes DL Jr, Ramirez V. The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro. Endocrinology. 1988;122(6):2851-60.
[19]
Schwartz Z, Boyan B. The effects of vitamin D metabolites on phospholipase A2 activity of growth zone and resting zone cartilage cells in vitro. Endocrinology. 1988;122(5):2191-8.
[20]
Takeuchi Y, Matsumoto T, Ogata E, Shishiba Y. 1,25-Dihydroxyvitamin D3 inhibits synthesis and enhances degradation of proteoglycans in osteoblastic cells. J Biol Chem. 1989;264(31):18407-13.
[21]
Bondarenko LB, Yakhimovich RI, Gogoman IV, Bauman VK, Valinietse MJ. Influence of 3b-fluoroVitamin D3 and 1a,25-dihydroxyvitamin D3 on chicken bone and cartilage collagens. Doklady Akad Nauk Ukr SSR. 1991; (7):138-43.
[22]
Bondarenko LB, Yakhimovich RI, Gogoman IV, Bauman VK. Influence of 3b-fluorovitamin D3 and 1a,25-dihydroxyvitamin D3 on aminoacid composition of chicken skin collagen. Doklady Akad Nauk Ukrainy. 1992; (3):122-6.
[23]
Bondarenko L. B., Yahimovich R. I., Bauman V. K. Influence of lα-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3on chicken bone, skin and cartilage collagens. Biopolym Cell. 1992; 8(5):38-43.
[24]
Kato Y, Shimazu A, Iwamoto M, Nakashima K, Koike T, Suzuki F, Nishii Y, Sato K. Role of 1,25-dihydroxycholecalciferol in growth-plate cartilage: inhibition of terminal differentiation of chondrocytes in vitro and in vivo. Proc Natl Acad Sci U S A. 1990;87(17):6522-6.
[25]
Beresford JN, Gallagher JA, Russell RG. 1,25-Dihydroxyvitamin D3 and human bone-derived cells in vitro: effects on alkaline phosphatase, type I collagen and proliferation. Endocrinology. 1986;119(4):1776-85.
[26]
Evans DV, Thavarajah M, Kanis JA. The effects of 24,25(OH)2D3 and 25(OH)2D3 on the cellular proliferation and synthesis of osteocalcin and alkaline phosphatase by human osteoblast-like cells in vitro. Calcified Tissue Int. 1990; 46(Suppl, N 2):18.
[27]
Inaba M, Burgos-Trinidad M, DeLuca HF. Characteristics of the 25-hydroxyvitamin D3- and 1,25-dihydroxyvitamin D3-24-hydroxylase(s) from HL-60 cells. Arch Biochem Biophys. 1991;284(2):257-63.
[28]
Morgan JW, Maizel AL, Clark J, Sharma S. 1,25-Dihydroxyvitamin D3 selectively inhibits FC R11. CD23 b isoform gene expression. J Cell Biochem. 1992; (Suppl. 166):290.
[29]
Koren R, Liberman UA, Maron L, Novogrodsky A, Ravid A. 1,25-Dihydroxyvitamin D3 acts directly on human lymphocytes and interferes with the cellular response to interleukin-2. Immunopharmacology. 1989;18(3):187-94.
[30]
Babarykin DA, Smiltnieks EKh, Valinietse MIu, Bauman VK. 24,25-Dihydroxyvitamin D3 modulates the effect of 1alpha-hydroxyvitamin D3 on B lymphocyte maturation in chickens. Vopr Med Khim. 1988;34(6):82-6.
[31]
Suda T, Abe E, Miyaura C, Tanaka H. Modulation of proliferation, differentiation, activation and fusion of hematopoietic cells by la,25-dihydroxyvitamin D3. Myelo-dysplast. syndromes: Pathophysiol. and treat. : Proc. symp. myclodysplast. syndromes (Kyoto, 28 Aug., 1987). Amsterdam etc., 1988: 95-121.
[32]
Billecocq A, Emanuel JR, Levenson R, Baron R. 1 alpha,25-dihydroxyvitamin D3 regulates the expression of carbonic anhydrase II in nonerythroid avian bone marrow cells. Proc Natl Acad Sci U S A. 1990;87(16):6470-4.
[33]
Tanaka Y, Bush KK, Klauck TM, Higgins PJ. Enhancement of butyrate-induced differentiation of HT-29 human colon carcinoma cells by 1,25-dihydroxyvitamin D3. Biochem Pharmacol. 1989;38(21):3859-65.
[34]
de Cremoux P, Calvo F, Lagier G, Lachat P, Abita JP, Maus M, Premont J. 1,25 Dihydroxyvitamin D3 modulates adenylate cyclase activity of the human breast cancer cell line T47D through increased synthesis of Gs. Biochem Pharmacol. 1989;38(18):3111-4.
[35]
Kawaguchi N, DeLuca HF, Noda M. Id gene expression and its suppression by 1,25-dihydroxyvitamin D3 in rat osteoblastic osteosarcoma cells. Proc Natl Acad Sci U S A. 1992;89(10):4569-72.
[36]
Mykkanen HM, Wasserman RH. Reactivity of sulfhydryl groups in the brush-border membranes of chick duodena is increased by 1,25-dihydroxycholecalciferol. Biochim Biophys Acta. 1990;1033(3):282-6.
[37]
Shionome M, Shinki T, Takahashi N, Hasegawa K, Suda T. 1 alpha,25-dihydroxyvitamin D3 modulation in lipid metabolism in established bone marrow-derived stromal cells, MC3T3-G2/PA6. J Cell Biochem. 1992;48(4):424-30.
[38]
Okazaki T, Bielawska A, Bell RM, Hannun YA. Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem. 1990;265(26):15823-31.
[39]
Baran DT, Sorensen AM, Honeyman TW, Ray R, Holick MF. Rapid actions of 1 alpha,25-dihydroxyvitamin D3 on Ca2+ and phospholipids in isolated rat liver nuclei. FEBS Lett. 1989;259(1):205-8.
[40]
Schwartz Z, Schlader DL, Swain LD, Boyan BD. Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities. Endocrinology. 1988;123(6):2878-84.
[41]
Wakasugi M, Noguchi T, Inoue M, Kazama Y, Tawata M, Kanemaru Y, Onaya T. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins. 1991;42(2):127-36.
[42]
Bondarenko LB, Harchenko OV, Butovich IA. Vitamin D3 and 1,25-dihydroxyvitamin D3 –inhibitors of 5-lipoxygenase. Biopolym Cell. 1992; 8(6):41-3.
[43]
Yakhimovich RI, Bondarenko LB, Gogoman IV, Valinietse MJ, Bauman VK. Influence of 3b-fluorovitamin D3 and 1a,25-dihydroxyvitamin D3 on some indices of serum chickens. Doklady Akad Nauk Ukr SSR. 1991; (5):149-51.
[44]
Bondarenko LB, Yahimovich RI, Bauman VK. Influence of lα-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on serum pool of free aminoacids and other indices. Biopolym Cell. 1993; 9(1):15-8.
[45]
Takeuchi Y, Matsumoto T, Ogata E, Shishiba Y. 1,25-Dihydroxyvitamin D3 inhibits synthesis and enhances degradation of proteoglycans in osteoblastic cells. J Biol Chem. 1989;264(31):18407-13.
[46]
Franceschi RT, Romano PR, Park KY. Regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D3 in human osteosarcoma cells. J Biol Chem. 1988;263(35):18938-45.
[47]
Silbermann M, von der Mark K, Mirsky N, van Menxel M, Lewinson D. Effects of increased doses of 1,25 dihydroxyvitamin D3 on matrix and DNA synthesis in condylar cartilage of suckling mice. Calcif Tissue Int. 1987;41(2):95-104.